Vimarsana
Biggest News Aggregation in the World

Joe Trebley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joe Trebley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joe Trebley Today - Breaking & Trending Today

Biofilm probiotic effective in preventing necrotizing enterocolitis in piglet model - Vimarsana News

Biofilm probiotic effective in preventing necrotizing enterocolitis in piglet model

Necrotizing enterocolitis (NEC) is a debilitating and deadly condition that affects infants who were born preterm.

 - Vimarsana News

Researchers have developed a novel probiotic system that harnesses the durability of biofilms to improve the administration of probiotics to patients, protecting against necrotizing enterocolitis (NEC) in piglet model, a new study said on ...

Probiotics given in biofilm state protect intestines, brain in NEC model: Study - Vimarsana News

Probiotics given in biofilm state protect intestines, brain in NEC model: Study

Researchers have developed a novel probiotic system that harnesses the durability of biofilms to improve the administration of probiotics to patients, protecting against necrotizing enterocolitis (NEC) in piglet model, a new study said on ...

Probiotics delivered in biofilm state protect - Vimarsana News

Probiotics delivered in biofilm state protect

<p>Researchers at Nationwide Children&rsquo;s Hospital have been working on a novel solution to prevent NEC. They have developed a novel probiotic system that harnesses the durability of biofilms to improve the administration of probiotics to patients. It has been licensed to Scioto Biosciences. Their latest study, published in <em>Nature Scientific Reports</em>, describes the use of a biofilm formulation of <em>Limosilactobacillus reuteri </em>(<em>Lr</em>) to prevent NEC in a piglet model.</p>

Monon Bioventures receives SBIR grant to develop glioblastoma therapeutic created at Purdue - Vimarsana News

Monon Bioventures receives SBIR grant to develop glioblastoma therapeutic created at Purdue

Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.